Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628043 | 0.83 | TYR (0.46) | TSHRMAPK1PTGS2 | |
| SCHEMBL28318821 | 0.83 | ALDH1A1 (0.47) | ALDH1A1CYP2A6CA1CA2CA12 | |
| SCHEMBL2915186 | 0.83 | AKR1C3 (0.58) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 | |
| SCHEMBL29533915 | 0.83 | AKR1C3 (0.58) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 | |
| SCHEMBL616312 | 0.83 | AKR1C3 (0.58) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 | |
| SCHEMBL30218646 | 0.83 | AKR1C3 (0.58) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 | |
| SCHEMBL4831638 | 0.83 | AKR1C3 (0.58) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 | |
| SCHEMBL4775938 | 0.80 | ALDH1A1 (0.52) | ALDH1A1CYP2A6CA1CA2CA12 | |
| SCHEMBL182145 | 0.80 | ALDH1A1 (0.52) | ALDH1A1CYP2A6CA1CA2CA12 | |
| SCHEMBL11740336 | 0.80 | AKR1C3 (0.55) | CYP2A6TSHRTDP1L3MBTL1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| CN-114956932-B | Synthesis method of polysubstituted chiral tetrahydroquinoline compound | 东北大学秦皇岛分校 | 2023-11-10 | — | — | CN | claimed |
| CN-114956932-A | Synthesis method of polysubstituted chiral tetrahydroquinoline compound | 东北大学秦皇岛分校 | 2022-08-30 | — | — | CN | claimed |
| WO-2022076359-A1 | A PROCESS FOR MAKING ENOL ETHERS | EASTMAN CHEMICAL COMPANY (US) | 2022-04-14 | — | — | WO | claimed |
| EP-3166586-B1 | ANHYDROUS OIL BASED ON DELIVERY PARTICLES CONTAINING A BENEFIT AGENT | OREAL (FR) | 2020-04-15 | — | — | EP | claimed |
| EP-3166575-B1 | ANHYDROUS SOFT SOLID COMPOSITION BASED ON PARTICLES ENCAPSULATING A BENEFIT AGENT | OREAL (FR) | 2020-04-15 | — | — | EP | claimed |
| EP-3166580-B1 | SOLID ANHYDROUS COSMETIC OR DERMATOLOGIC COMPOSITION BASED ON DELIVERY PARTICLES CONTAINING A BENEFIT AGENT | OREAL (FR) | 2020-03-18 | — | — | EP | claimed |
| EP-3166578-B1 | ANHYDROUS AEROSOL COMPOSITION BASED ON PARTICULES CONTAINING AN ENCAPSULATED BENEFIC AGENT | OREAL (FR) | 2020-03-18 | — | — | EP | claimed |
| CN-109180515-A | A kind of synthetic method of N- [2- hydroxyl -2- (4- methoxyphenyl) ethyl] cinnamamide | 苏利制药科技江阴有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-103958047-B | Microcapsules and their use | 弗门尼舍有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-103958047-A | Microcapsules and their use | FIRMENICH & CIE | 2014-07-30 | — | — | CN | claimed |
| CN-122036479-A | Preparation method of chiral propargyl substituted aldehyde compound | 扬州大学 | 2026-05-15 | — | — | CN | disclosed |
| US-12624309-B2 | Enol ether properfume | FIRMENICH SA (CH) | 2026-05-12 | — | — | US | disclosed |
| US-12616644-B2 | Polyurethane gels | GRANT INDUSTRIES, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12617602-B2 | Aerosol dispenser and nozzle with reduced drip | THE PROCTER & GAMBLE COMPANY (US) | 2026-05-05 | — | — | US | disclosed |
| EP-0220792-A1 | A method for producing 2-aryl-propionaldehydes | HAMARI YAKUHIN KOGYO KABUSHIKI KAISHA also known as HAMARI CHEMICALS, LTD. (JP) | 1987-05-06 | — | — | EP | disclosed |
| US-4364952-A | Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use | BAYER AKTIENGESELLSCHAFT (DE) | 1982-12-21 | — | — | US | disclosed |
| US-4355184-A | BY REACTING AN ALDEHYDE WITH AN ALKALI METAL SALT OF ACETOACETIC | NIPPON SODA COMPANY LIMITED (JP) | 1982-10-19 | — | — | US | disclosed |
| EP-0042093-A2 | 4-Aralkyl-1,4-dihydropyridines, processes for praparing them, their use as medicines and preparation thereof | BAYER AG (DE) | 1981-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616644-B2 | Polyurethane gels | DAGLB, DEGS1, CUTA | ALDH1A1 2864/4885CYP2A6 1856/4885CA1 2371/4885 |
| US-12617602-B2 | Aerosol dispenser and nozzle with reduced drip | EXOSC9, DVL1, DVL3 | ALDH1A1 1261/4885CYP2A6 3969/4885CA1 1336/4885 |
| US-12624309-B2 | Enol ether properfume | CYP2E1, CBR1, ADH5 | ALDH1A1 33/4885CYP2A6 51/4885CA1 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.